Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 15, Number 7—July 2009

Dispatch

Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, Israel

Shmuel Stienlauf1Comments to Author , Vered Yahalom1, Eli Schwartz, Eilat Shinar, Gad Segal, and Yechezkel Sidi
Author affiliations: Sheba Medical Center, Tel Hashomer, Israel (S. Stienlauf, E. Schwartz, G. Segal, Y. Sidi); Tel Aviv University, Tel Aviv, Israel (S. Stienlauf, E. Schwartz, G. Segal, Y. Sidi); Magen David Adom National Blood Services, Ramat Gan, Israel (V. Yahalom, E. Shinar).; 1These authors contributed equally to this article.

Main Article

Table

Prevalence of HTLV-1 in blood donors from different countries of origin, Israel, 1995–1998*

Country No. HTLV-1 carriers No. blood bank donors No. carriers/ 100,000 donors
Iran 16 31,776 50.4
Romania 12 73,971 14.9
Iraq 7 68,857 10.2
Russian Federation 7 111,109 6.3
Turkey 4 25,054 16
Poland 3 70,172 4.3
Israel 3 294,342 1.0
Morocco 3 144,014 2.1
United States 3 49,204 6.1
Yugoslavia† 2 3,181 62.9
Uruguay 2 3,552 56.3
Argentina 2 20,898 9.6
Chile 2 2,101 95.2
Czechoslovakia† 1 11,149 9.0
Brazil 1 4,217 23.7
Niger 1 1
Ethiopia 1 3,412 29.3
Egypt 1 21,245 4.7
Yemen 1 36,052 2.8
Libya 1 21,427 4.7

*HTLV-1, human T-lymphotropic virus type 1.
†Country no longer exists.

Main Article

1These authors contributed equally to this article.

TOP